Peritoneal Carcinomatosis research hub

A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

This study is testing a new treatment called Radspherin for advanced ovarian, fallopian tube, or peritoneal cancers. It aims to see how well it works and if it's safe when given with standard chemotherapy and surgery for people whose cancer is suitable for this combined approach.